Intuitive Genomics, Inc.

Intuitive Genomics, Inc. specializes in bioinformatics, providing advanced web-based solutions for genomic analysis. Their platform integrates diverse genomic datasets to deliver insights for researchers and institutions in genomics and personalized medicine. Intuitive Genomics, Inc.

was founded in 2010 and operates out of St. Louis, US. The company focuses on bioinformatics and has undergone a strategic pivot to enhance its offerings in genomic analytics. In December 2013, the company was acquired by NewLeaf Symbiotics, a portfolio company of Open Prairie Ventures, Pangaea Ventures, and RockPort Capital Partners.

The financial terms of the acquisition were not disclosed. Intuitive Genomics operates primarily in the field of bioinformatics, offering advanced web-based solutions designed to facilitate genomic analysis. Their core product suite includes a platform that integrates various genomic datasets to provide insights and analytics for researchers and institutions working in genomics and personalized medicine. The services aim to solve complex data analysis challenges faced by scientists, clinicians, and pharmaceutical companies engaged in genomic research and development.

By leveraging sophisticated algorithms and machine learning techniques, Intuitive Genomics enhances the accuracy and efficiency of genetic studies, thereby assisting in the advancement of precision medicine. The company primarily serves clients in North America and Europe, targeting academic institutions, healthcare organizations, and biotech firms that require robust tools for genomic data interpretation. Intuitive Genomics generates revenue through a subscription-based model, providing clients with access to its proprietary analytics platform. The typical transaction structure involves annual or monthly subscription plans, allowing users to utilize the platform's capabilities tailored to their specific research needs.

Different tiers of subscriptions offer varied levels of access, with flagship products designed to cater to a range of customer requirements, from individual researchers to large-scale institutions. Clients benefit from a comprehensive suite of tools that streamline genomic analysis and data visualization processes, thereby enhancing their research outcomes. The company’s revenue model fosters long-term partnerships with its clientele, ensuring ongoing access to updated features and support within the subscription framework. Following the acquisition in December 2013, Intuitive Genomics plans to develop new products aimed at expanding its analytics platform.

The company is also targeting expansion into additional markets in Europe by the end of 2024, aiming to diversify its client base. The recent acquisition deal will provide the necessary resources to support product development and market expansion initiatives.